logo
Plus   Neg
Share
Email

Teva Pharmaceutical CFO Michael McClellan To Step Down - Quick Facts

Israeli generic medicines producer Teva Pharmaceutical Industries (TEVA) announced Wednesday that Executive Vice President and Chief Financial Officer Michael McClellan has decided to step down from his role as CFO due to personal reasons requiring him to be located near his family.

Teva has initiated a search to identify its next CFO. McClellan is expected to remain in his role through the announcement of third quarter results to assist with a smooth transition.

McClellan was appointed Teva's CFO in November 2017 after serving as Senior Vice President and Interim Group CFO from July 2017. From 2015 to November 2017, McClellan served as senior vice president and CFO, Global Specialty Medicines.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Deutsche Post DHL Group were gaining around 5 percent in the morning trading in Germany after the package delivery and supply chain management company reported Tuesday significantly higher profit in its third quarter. Looking ahead, the company anticipates a traditionally strong holiday season in the fourth quarter. The company also confirmed its annual earnings outlook. A New York regulator has launched an investigation into the credit card practices of Goldman Sachs Group Inc. for alleged gender discrimination in determining limits for Apple's new credit card, which is administered by Goldman Sachs. The Apple Card, Apple's first credit card, was introduced by the tech giant in March this year in partnership with Goldman Sachs and Mastercard. The U.S. Food and Drug Administration approved the first therapy for patients with a rare inherited blood disorder called beta thalassemia. Celegene's Reblozyl is also the first and only FDA-approved erythroid maturation agent, a new class of therapy for such patients. The regulator approved Reblozyl for treating anemia in adult patients with beta thalassemia who require regular RBC transfusions.
Follow RTT
>